Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Rhea-AI Summary
Lantheus (NASDAQ: LNTH) announced that Vice President of External Manufacturing John Wiggins will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference at 8:40 a.m. ET on Tuesday, June 9. A live webcast and 30-day replay will be available on the company’s investor website.
Positive
- None.
Negative
- None.
News Market Reaction – LNTH
In the Jun 3 session, LNTH gained 4.10%, reflecting a moderate positive market reaction. Our momentum scanner triggered 16 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 27 | Investor conference | Neutral | -1.0% | Announcement of William Blair fireside chat and webcast access details. |
| May 21 | Clinical data update | Positive | -1.7% | New radiodiagnostic data presentations at the 2026 SNMMI Annual Meeting. |
| May 19 | Clinical data update | Positive | -0.6% | Radiopharmaceutical data presentations at the 2026 ASCO Annual Meeting. |
| May 07 | Earnings and approvals | Positive | +5.6% | Q1 2026 results with strong EPS, FDA approval and reaffirmed guidance. |
| Apr 23 | Earnings call notice | Neutral | -0.1% | Scheduling of Q1 2026 earnings call and webcast information. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent data- and conference-related announcements often saw flat to negative next-day moves, while solid earnings with approvals drew a stronger positive reaction.
Over the past months, Lantheus has combined investor outreach with clinical and financial milestones. Conference participation and data announcements on May 19 and May 21 around radiopharmaceutical and radiodiagnostic presentations saw modest negative reactions. In contrast, the May 7 Q1 2026 earnings report, featuring $377.3M revenue, strong EPS and multiple FDA-related achievements, drew a notable positive move. Today’s Goldman Sachs conference appearance resembles prior non-fundamental investor events, which historically triggered limited directional shifts.
Key Terms
radiopharmaceutical-focused medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
BEDFORD, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient outcomes, today announced John Wiggins, Vice President, External Manufacturing, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference at 8:40 a.m. ET on Tuesday, June 9.
To access the live webcast of the presentations, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcasts will be available on the Company’s website for at least 30 days following the live presentation.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland, and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com
